Technology

Detection of RNA biomarkers by the RNAscope™ assay using IHC HDxTM Reference Standards from Horizon Discovery

Reference standards for histopathological assays are critical for validating, optimizing, and routinely monitoring assay performance in order to maintain quality control and ensure the sensitivity, specificity, and accuracy of your assay. The RNAscope™ ISH assay is a robust technology that identifies RNA expression patterns and localization at the single cell level with morphological context. Here we demonstrate the application of the RNAscope™ assay on the IHC HDx™ Reference Standards from Horizon Discovery. The benefits of this compatibility include:

Whitepaper RNAscope ISH and IHC Reference Standards from Horizon Discovery

Akt Signaling Pathway

Akt Signaling Pathway

 

Publications

There are several publications where the Akt gene and RNAscope ISH are referenced.

Let's get started on your project.

Highly sensitive and specific in situ detection of circular RNAs using the BaseScope assay

Recently, a new universal class of endogenous noncoding RNAs that is generated by “head-to-tail’ splicing in eukaryotes gained considerable interest. This alternative spicing event results in the covalent linkage of the 5’ end of one exon with the 3’ end of another exon and creates stable single-stranded circular RNA molecules (circRNAs) (Andreeva and Cooper 2015, Salzman et al. 2013, Salzman 2016). These highly conserved circRNAs are characterized by tissue- and developmental stage-specific expression patterns (Memczak et al. 2013).

RNAscope™ ISH to detect breast cancer-related markers

Breast cancer is a complex disease with great clinical and molecular heterogeneity that requires accurate assessment of known breast cancer biomarkers, such as HER2, estrogen receptor (ER) and progesterone receptor (PgR), as well as the discovery of emerging potential targets, for the precise treatment of breast tumors.

Read breast cancer related publications

RNAscope™ ISH to detect lung cancer-related markers

Lung cancer is the leading cause of cancer deaths worldwide. Lung tumors are highly heterogeneous, with great variability between individual patients, cancer types and stages, as well as intra-tumor heterogeneity. This variability poses a considerable challenge in identifying and validating clinically relevant lung cancer biomarkers. Therefore, spatially-mapped gene expression at the cellular level is crucial to understand the cell-to-cell interactions in the tumor and the cellular makeup within the complex tumor microenvironment (TME). 

Read lung cancer related publications

Splice Variant Analysis using BaseScope™ Assay

Alternative splicing of exons in pre-mRNA can lead to the expression of multiple different mature mRNAs from an individual gene, known as splice variants. Splice variants have been shown to play significant roles in human disease, particularly cancer and neurological disorders and they often are differentially regulated across tissues and cells and during disease progression. However, the localization of the precise cells expressing specific splice variants in a complex tissue environment has been limited by the lack of sensitive and reproducible technologies.

BaseScope probes for Splice Variant List

 

  • APOBEC3A
  • APOBEC3B
  • AR
  • CD19
  • CTAG2
  • EGFR
  • ERBB2
  • FCGR2A
  • FCGR2B
  • FCGR3A
  • HOXB-AS3
  • IL4
  • IL6
  • LILRB1
  • LOC101927027
  • MAGEA2
  • MAGEA4
  • MAGEA8
  • MAGEA10
  • MAGEA11
  • MAGEA12
  • MET
  • MICA
  • PRAME
  • SLC1A2
  • XBP1
 

Want to order a probe or don't find your gene of interest in this list? Contact your Account Manager 

Species-specific gene expression profiling of PDX tumors and humanized mice by RNAscope™ ISH

Application note

In our application note "Species-specific gene expression profiling of patient-derived xenograft tumors by the RNAscope™ in situ hybridization assay" we used the RNAscope™ technology to visualize gene expression in the human tumor and mouse stroma of two types of PDX mouse models with specially-designed species-specific probes, allowing for the specific detection and visualization of human- and mouse-specific gene targets with morphological context in the same FFPE sample.

Species-specific gene expression profiling of patient-derived xenograft tumors by the RNAscope™ in situ hybridization assay

RNAscope™ in situ hybridization to detect prostate cancer-related markers

RNAscope™ in situ hybridization (ISH) offers a reliable and robust method for the detection and validation of prostate cancer (PCa)-related biomarkers within the tissue environment. 

How RNAscope™ ISH has been applied to examine PCa-related markers:

Researchers in the Spotlight

In our Researcher in the Spotlight Section you can learn how other researchers use RNAscope™ technology to help them advance their research in unique ways by adding morphological context to RNA expression analysis, and more.

Interview with Dr Rohit Mehra:
"Realising the potential of Iong noncoding RNA as a cancer biomarker - From NGS discovery to validation with RNA in situ Hybridization"

Interview with Dr Nallasivam Palanisamy:
"Development of Prostate Cancer Personalized Medicine - Advancing analysis of prostate tumor molecular heterogeneity by combined immunohistochemistry and novel RNA in situ hybridization"

Related Publications

RNAscope™ ISH has been applied and published in many prostate cancer articles. 

Utilization of RNAscope™ ISH to detect gene expression in mouse models

The mouse has become a key mammalian model system for research due to its genetic and physiological similarities to humans. The RNAscope™ and BaseScope™ in situ hybridization (ISH) assays can both be applied as methods to detect mouse gene expression with morphological context in a multitude of mouse models:

Related Publications

RNAscope ISH has been featured in ~200 mouse model publications. 

Pages

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com